Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 892 of 5804
-
Could a simple Self-Swap replace the speculum for cervical cancer screening?
Diagnosis OngoingThis clinical trial evaluates the use of self-collected vaginal samples for human papillomavirus (HPV) testing in patients referred for a colposcopy and/or cervical excisional procedures to improve cervical cancer prevention. HPV is a common virus which usually causes infections …
Phase: NA • Sponsor: National Cancer Institute (NCI) • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New bladder cancer combo aims to help patients who Can't take chemo
Disease control Recruiting nowSTAR-EV will evaluate the combination of enfortumab vedotin plus radiotherapy (RT) as neoadjuvant treatment for muscle invasive bladder cancer prior to radical cystectomy surgery. The study will use "dose escalation" to evaluate the safety and efficacy of study treatment at three…
Phase: PHASE1, PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 26, 2026 17:25 UTC
-
Oral chemotherapy pill tested for advanced breast cancer
Disease control OngoingThis study looks at how well oral vinorelbine works in treating advanced breast cancer. It looks at women who have already had this treatment or are currently having it.
Sponsor: Pierre Fabre Medicament • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New biologic IBI311 shows promise for thyroid eye disease in early trial
Disease control CompletedThis is a multicenter, randomized, double-masked phase II study evaluating the efficacy and safety of IBI311 in subjects with inactive or active thyroid eye disease. Approximately 36 subjects meeting the study eligibility criteria will be randomly assigned to the 3-10 mg group, 3…
Phase: PHASE2 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New placental patch shows promise for diabetic foot ulcers
Disease control CompletedThis trial is a multicenter, randomized, controlled study designed to evaluate the safety and efficacy of BioREtain® Amnion Chorion (BR-AC) plus standard of care versus standard of care only in the treatment of diabetic foot ulcers. The trial design will control potential variabl…
Phase: NA • Sponsor: BioStem Technologies • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New daily pill shows promise for rheumatoid arthritis in early trial
Disease control CompletedThe goal of this multicenter, randomized, double-blind, placebo-controlled phase 2 clinical trial is to evaluate the efficacy and safety of proximod in active rheumatoid arthritis patients with inadequate response or intolerance to conventional synthetic disease-modifying antirhe…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Blood test breakthrough could end painful liver biopsies for NASH patients
Diagnosis OngoingThe main objective is to study and validate a new approach for NASH and liver fibrosis diagnosis and personalized follow-up based on monocyte biomarkers and plasma metabolites. The investigators will assess if PLIN2 and RAB14 can be used not only to identify subjects with NASH an…
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
Your smartwatch could spot sleep apnea: study tests At-Home screening
Diagnosis CompletedThe purpose of this study is to evaluate the diagnostic value of smartphones and watches for OSA screening. The study will be conducted in individuals suspected of having OSA. Subjects will undergo "gold standard" PSG assessment (overnight polysomnography with staff supervision) …
Sponsor: Peking University First Hospital • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
New hope for transplant patients with stubborn CMV infection
Disease control Recruiting nowThis study is a survey in Japan of Maribavir tablets used to treat participants with Cytomegalovirus (CMV) infection refractory to existing anti-CMV therapy in organ transplantation (including hematopoietic stem cell transplantation). The main aim of the study is to check if tre…
Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
AI and gut bacteria may predict who gets hooked on opioids
Knowledge-focused OngoingThe primary goal of this proposal is to validate a novel genomic and microbiome predictive model that may be used to assess a person's risk of developing opioid use disorder (OUD). The following will be tested: (1) MODUS (Measuring risk for Opioid use Disorder Using SNPs), which …
Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
Robot-Assisted knee surgery tests custom alignment for Longer-Lasting implants
Disease control Recruiting nowRobotic knee surgery makes it possible to adopt different alignment philosophies in total knee arthroplasty. The classical operation where the knee is placed in a neutral manner, the so called mechanical alignment, has been used for decades. The kinematical alignment has recently…
Phase: NA • Sponsor: Helse Møre og Romsdal HF • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Exercise as brain medicine: could a workout sharpen the minds of those with bipolar disorder?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the impact of Physical Exercise (PE), as an adjuvant treatment, on the cognition of patients diagnosed with Bipolar Disorder who present cognitive impairments, as well as its impact on quality of life and functionality and its associ…
Phase: NA • Sponsor: Beny Lafer • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Emergency room could be the starting point for alcohol addiction treatment
Disease control Recruiting nowThe proposed study will be the first randomized clinical trial to evaluate a comprehensive Emergency Department (ED)-based intervention for moderate to severe Alcohol Use Disorder (AUD) combining Screening, Brief Intervention and Referral to Treatment (SBIRT) with ED-initiated me…
Phase: PHASE3 • Sponsor: Yale University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could an apple watch spot hidden heart problems in kids?
Diagnosis CompletedSpecific Aim #1 - To determine the accuracy of Apple Watch ECG tracings heart rate in children. Specific Aim #2 - To determine if extended monitoring with the Apple Watch can identify arrhythmia events that were not detected by short term clinical monitoring.
Phase: NA • Sponsor: Stanford University • Aim: Diagnosis
Last updated Jul 17, 2026 00:00 UTC
-
Could a simple monitor transform blood sugar control for millions with type 2 diabetes?
Disease control OngoingThis multi-center study is a 26-week randomized controlled trial (RCT) in which adults (≥18 years) with type 2 diabetes (T2D) not using insulin and managed in a primary-care setting will be randomly assigned 1:1 to either use of real-time continuous glucose monitoring (CGM) or ro…
Phase: NA • Sponsor: DexCom, Inc. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New Weight-Loss shot shows promise in Mid-Stage trial
Disease control CompletedThis study will evaluate the percentage change from baseline in weight after 24 weeks of treatment with ZT002 Injection in subjects with overweight/obesity.
Phase: PHASE2 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Evolution-Inspired drug sequence aims to outsmart breast cancer
Disease control Recruiting nowThe purpose of the study is to test a treatment strategy with currently approved drugs to see if it is practical to administer the available drugs in a new way that researchers hope could be more effective in treating metastatic breast cancer.
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Acupuncture needles take on Crohn's: a new hope for fewer Flare-Ups?
Disease control Recruiting nowThe aim of this study was to further improve the clinical efficacy of acupuncture in delaying the clinical recurrence of CD and to explore the efficacy mechanism of acupuncture efficacy enhancement.
Phase: NA • Sponsor: Shanghai Institute of Acupuncture, Moxibustion and Meridian • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New injection shows promise for weight loss in early trial
Disease control CompletedThe study is designed to evaluate the preliminary efficacy, safety, population PK profile, and immunogenicity of CPX101 in subjects with obesity or overweight with weight related comorbidities but without diabetes mellitus.
Phase: PHASE2 • Sponsor: Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Lying a certain way after brain surgery may stop bleeds returning
Prevention Recruiting nowThis study aims to investigate the effectiveness and safety of body posture to improve intracranial pressure in preventing postoperative recurrence for chronic subdural hematoma
Phase: NA • Sponsor: Huashan Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:26 UTC